Highbridge Capital Management’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Highbridge Capital Management’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-38,181	Closed	-$523K	–	1823
2016 Q3	$523K	Sell	38,181 -18,434	-33%	-$185K	0.01%	769
2016 Q2	$418K	Buy	+56,615	New	+$425K	0.01%	918
2014 Q3	–	Sell	-188,100	Closed	-$1.2M	–	1490
2014 Q2	$1.2M	Buy	+188,100	New	+$1.29M	0.01%	521
2013 Q4	–	Sell	-204,450	Closed	-$3.76M	–	1492
2013 Q3	$3.76M	Buy	204,450 +170,217	+497%	+$3.3M	0.04%	386
2013 Q2	$599K	Buy	+34,233	New	+$607K	0.01%	822

Other funds holding ARIA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Highbridge Capital Management's ARIA Position: Q4 2016 in Review

Highbridge Capital Management sold out of Ariad Pharmaceuticals Inc (ARIA) in Q4 2016, closing a stake of 38,181 shares — an estimated $523K sold.

Highbridge Capital Management first reported a position in ARIA in Q2 2013 and held it in 5 quarters. The position peaked at $3.76M in Q3 2013. 200 funds tracked by Wall St. Rank hold ARIA as of Q4 2016.

Highbridge Capital Management reported no remaining Ariad Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
Highbridge Capital Management sold 38,181 Ariad Pharmaceuticals Inc shares in Q4 2016, an estimated $523K.
Highbridge Capital Management first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
Highbridge Capital Management's Ariad Pharmaceuticals Inc position peaked at $3.76M in Q3 2013.
200 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q4 2016.

Based on Highbridge Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.